Deletion of 15q11.2(BP1-BP2) region: Further evidence for lack of phenotypic specificity in a pediatric population

American Journal of Medical Genetics, Part A

Volumn 167, Issue 9, 2015, Pages 2098-2102

  Hashemi, Bita ^a   Bassett, Anne ^b   Chitayat, David ^a,c   Chong, Karen ^c   Feldman, Mark ^a   Flanagan, Janine ^d   Goobie, Sharan ^e   Kawamura, Anne ^f   Lowther, Chelsea ^b   Prasad, Chitra ^e   Siu, Victoria ^e   So, Joyce ^a,b,g   Tung, Sharon ^h   Speevak, Marsha ⁱ   Stavropoulos, Dimitri J ^a   Carter, Melissa T ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d ST JOSEPH S HEALTH CENTRE   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f HOLLAND BLOORVIEW KIDS REHABILITATION HOSPITAL   (Canada)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h North Bay Parry Sound District Health Unit   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

Author keywords

15q11.2; Array CGH; Autism; Developmental delay; Epilepsy; Microdeletion

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BONE DISEASE; CHILD; CLEFT PALATE; CLINICAL ARTICLE; CLINICAL FEATURE; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; EYE DISEASE; FACE DYSMORPHIA; FEEDING DIFFICULTY; FEMALE; GENE DELETION; GENETIC COUNSELING; GENETIC VARIABILITY; HEART DISEASE; HUMAN; INHERITANCE; MALE; MICROARRAY ANALYSIS; MICROCEPHALY; MUSCLE HYPOTONIA; NEUROLOGIC DISEASE; NEWBORN; PHENOTYPE; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SEIZURE; SHORT STATURE; SPEECH DELAY; CHROMOSOME 15; CHROMOSOME DELETION; GENETICS; INFANT; PRESCHOOL CHILD; SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 15; DEVELOPMENTAL DISABILITIES; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PHENOTYPE; SYNDROME; YOUNG ADULT;

EID: 84939472330     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.37134     Document Type: Article

References (19)

1. Abdelmoity AT, LePichon JB, Nyp SS, Soden SE, Daniel CA, Yu S. 2012. 15q11.2 Proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features. J Dev Behav Pediatr 33:570-576.
2. Burnside RD, Pasion R, Mikhail FM, Carroll AJ, Robin NH, Youngs EL, Gadi IK, Keitges E, Jaswaney VL, Papenhausen PR, Potluri VR, Risheg H, Rush B, Smith JL, Schwartz S, Tepperberg JH, Butler MG. 2011. Microdeletion/microduplication of proximal 15q11.2 between BP1 and B P2: A susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet 130:517-528.
3. Cafferkey M, Ahn JW, Flinter F, Ogilvie C. 2014. Phenotypic features in patients with 15q11.2(BP1-BP2) deletion: Further delineation of an emerging syndrome. Am J Med Genet Part A 164A:1916-1922.
4. Chaste P, Sanders SJ, Mohan KN, Klei L, Song Y, Murtha MT, Hus V, Lowe JK, Willsey AJ, Moreno-De-Luca D, Yu TW, Fombonne E, Geschwind D, Grice DE, Ledbetter DH, Lord C, Mane SM, Martin DM, Morrow EM, Walsh CA, Sutcliffe JS, State MW, Martin CL, Devlin B, Beaudet AL, Cook EH Jr, Kim SJ. 2014. Modest impact on risk for autism spectrum disorder of rare copy number variants at 15q11.2, specifically breakpoints 1 to 2. Autism Res 7:355-362.
5. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J, Shashi V, Johnson K, Rehder C, Ballif BC, Shaffer LG, Eichler EE. 2011. A copy number variation morbidity map of developmental delay. Nat Genet 43:838-846.
6. Chai JH, Locke DP, Greally JM, Knoll JH, Ohta T, Dunai J, Yavor A, Eichler EE, Nicholls RD. 2003. Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. Am J Hum Genet 73:898-925.
7. de Kovel CG, Trucks H, Helbig I, Mefford HC, Baker C, Leu C, Kluck C, Muhle H, von Spiczak S, Ostertag P, Obermeier T, Kleefuss-Lie AA, Hallmann K, Steffens M, Gaus V, Klein KM, Hamer HM, Rosenow F, Brilstra EH, Trenité DK, Swinkels ME, Weber YG, Unterberger I, Zimprich F, Urak L, Feucht M, Fuchs K, Møller RS, Hjalgrim H, De Jonghe P, Suls A, Rückert IM, Wichmann HE, Franke A, Schreiber S, Nürnberg P, Elger CE, Lerche H, Stephani U, Koeleman BP, Lindhout D, Eichler EE, Sander T. 2010. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 133:23-32.
8. De Wolf V, Brison N, Devriendt K., Peeters H. 2013. Genetic counseling for susceptibility loci and neurodevelopmental disorders: The del15q11.2 as an example. Am J Med Genet Part A 161A:2846-2854.
9. Doornbos M, Sikkema-Raddatz B, Ruijvenkamp CA, Dijkhuizen T, Bijlsma EK, Gijsbers AC, Hilhorst-Hofstee Y, Hordijk R, Verbruggen KT, Kerstjens-Frederikse WS, van Essen T, Kok K, van Silfhout AT, Breuning M, van Ravenswaaij-Arts CM. 2009. Nine subjects with a microdeletion 15q11. 2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances. Eur J Med Genet 52:108-115.
10. Mefford HC, Cooper GM, Zerr T, Smith JD, Baker C, Shafer N, Thorland EC, Skinner C, Schwartz CE, Nickerson DA, Eichler EE. 2009. A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res 19:1579-1585.
11. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, Scherer SW, Spinner NB, Stavropoulos DJ, Tepperberg JH, Thorland EC, Vermeesch JR, Waggoner DJ, Watson MS, Martin CL, Ledbetter DH. 2010. Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86:749-764.
12. Mullen SA, Carvill GL, Bellows S, Bayly MA, Trucks H, Lal D, Sander T, Berkovic SF, Dibbens LM, Scheffer IE, Mefford HC. 2013. Copy number variants are frequent in genetic generalized epilepsy with intellectual disability. Neurology 81:1507-1514.
13. Murthy SK, Nygren AO, El Shakankiry HM, Schouten JP, Al Khayat AI, Ridha A, Al Ali MT. 2007. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment. Cytogenet Genome Res 116:135-140.
14. Reinthaler EM, Lal D, Lebon S, Hildebrand MS, Dahl HH, Regan BM, Feucht M, Steinböck H, Neophytou B, Ronen GM, Roche L, Gruber-Sedlmayr U, Geldner J, Haberlandt E, Hoffmann P, Herms S, Gieger C, Waldenberger M, Franke A, Wittig M, Schoch S, Becker AJ, Hahn A, Männik K, Toliat MR, Winterer G; 16p11.2, European Consortium, Lerche H, Nürnberg P, Mefford H, Scheffer IE, Berkovic SF, Beckmann JS; EPICURE Consortium; EuroEPINOMICS Consortium, Sander T, Jacquemont S, Reymond A, Zimprich F, Neubauer BA. 2014. 16p11.2 600kb Duplications confer risk for typical and atypical Rolandic epilepsy. Hum Mol Genet 23:6069-6080.
15. Rosenfeld JA, Coe BP, Eichler EE, Cuckle H, Shaffer LG. 2013. Estimates of penetrance for recurrent pathogenic copy-number variations. Genet Med 15:478-481.
16. Soemedi R, Wilson IJ, Bentham J, Darlay R, Töpf A, Zelenika D, Cosgrove C, Setchfield K, Thornborough C, Granados-Riveron J, Blue GM, Breckpot J, Hellens S, Zwolinkski S, Glen E, Mamasoula C, Rahman TJ, Hall D, Rauch A, Devriendt K, Gewillig M, O'Sullivan J, Winlaw DS, Bu'Lock F, Brook JD, Bhattacharya S, Lathrop M, Santibanez-Koref M, Cordell HJ, Goodship JA, Keavney BD. 2012. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet 91:489-501.
17. Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S Bjornsdottir G3, Walters GB, Jonsdottir GA, Doyle OM, Tost H, Grimm O, Kristjansdottir S, Snorrason H, Davidsdottir SR, Gudmundsson LJ, Jonsson GF, Stefansdottir B, Helgadottir I, Haraldsson M, Jonsdottir B, Thygesen JH, Schwarz AJ, Didriksen M, Stensbøl TB, Brammer M, Kapur S, Halldorsson JG, Hreidarsson S, Saemundsen E, Sigurdsson E, Stefansson K. 2014. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505:361-366.
18. Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Möller HJ, Hartmann A, Shianna KV, Ge D, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di Forti M, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Mühleisen TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B; GROUP, Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nöthen MM, Peltonen L, Collier DA, St Clair D, Stefansson K. 2008. Large recurrent microdeletions associated with schizophrenia. Nature 455:232-236.
19. von der Lippe C, Rustad K, Heimdal OK, Rødningen . 2011. 15q11.2 microdeletion-Seven new patients with delayed development and/or behavioural problems. Eur J Med Genet 54:357-360.